BENLYSTA subst sèche 400 mg flac
7680615320026
CH-61532
L04AG04
07.15.0.
Reimbursement limitations:
BENLYSTA.Ein
Après la garantie de prise en charge des frais par l’assureur-maladie et consultation préalable du …
1 / 2
google
Details
- Product number
- 6153202
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: belimumabum 400 mg, acidum citricum monohydricum, natrii citras dihydricus, saccharum, polysorbatum 80 pro vitro.
Articles (1)
Benlysta 400 mg, Pulver zur Herstellung einer Infusionslösung
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 583.75
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2015
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 61532
- Drug name
- Benlysta, Pulver zur Herstellung einer Infusionslösung
- Galenic form
- PULPA
- ATC Code
- L04AG04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 14/06/2012
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BENLYSTA subst sèche 400 mg flac
- Description (DE)
- BENLYSTA Trockensub 400 mg Durchstf
- Market launch
- 14/06/2012
- Narcotic (BTM)
- No